PMV Pharmaceuticals PMVP Insider Ownership

NASDAQ PMVP
$1.30 +0.02 (+1.56%)
At close: Aug 20, 2026 · 4:00 PM EDT

Historic Insider Ownership Trends

PMVP's three largest insider shareholders as of August 04, 2026 are Advisors Llc Orbimed (TenPercentOwner, 4.98Mn shares), Partners X Lp Interwest (TenPercentOwner, 4.50Mn shares), David Henry Mack (President And Ceo, 451.11K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Advisors Llc Orbimed - 0 4,975,291 27 Oct, 2025
Arnold J Levine - 409,842 0 23 Sep, 2021
David Henry Mack President And Ceo 451,109 0 29 Oct, 2025
Partners X Lp Interwest - 4,469,911 32,569 14 Jul, 2021
Robert Ticktin General Counsel Coo 98,695 0 03 Jul, 2025
Winston Kung Coo, Cfo 10,600 0 30 Jan, 2022
Deepika Jalota Chief Development Officer 89,959 0 03 Jul, 2025
Leila Alland Chief Medical Officer 45,909 0 18 Sep, 2023
Michael Carulli Chief Financial Officer 60,146 0 03 Jul, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
05 Mar, 2026 David Henry Mack Employee Stock Option (right to buy) A 744,960 $0.00 744,960 D A
05 Mar, 2026 Robert Ticktin Employee Stock Option (right to buy) A 319,270 $0.00 319,270 D A
05 Mar, 2026 Robert Ticktin Employee Stock Option (right to buy) A 319,270 $0.00 319,270 D A
05 Mar, 2026 Robert Ticktin Employee Stock Option (right to buy) A 319,270 $0.00 319,270 D A
05 Mar, 2026 Deepika Jalota Employee Stock Option (right to buy) A 303,310 $0.00 303,310 D A
05 Mar, 2026 Michael Carulli Employee Stock Option (right to buy) A 240,000 $0.00 240,000 D A
27 Oct, 2025 David Henry Mack Common Stock A 220,643 $1.37 451,109 D M
27 Oct, 2025 David Henry Mack Employee Stock Option (right to buy) D 220,643 $0.00 0 D M
23 Oct, 2025 Advisors Llc Orbimed Common Stock D 1,000,000 $1.52 4,975,291 I S
10 Sep, 2025 Advisors Llc Orbimed Common Stock D 500,000 $1.80 5,975,291 I S
01 Jul, 2025 Robert Ticktin Common Stock D 23,151 $1.06 98,695 D S
01 Jul, 2025 Robert Ticktin Common Stock D 23,151 $1.06 98,695 D S
01 Jul, 2025 Robert Ticktin Common Stock D 23,151 $1.06 98,695 D S
01 Jul, 2025 David Henry Mack Common Stock D 58,411 $1.06 536,133 D S
01 Jul, 2025 Michael Carulli Common Stock D 28,249 $1.06 60,146 D S
01 Jul, 2025 Deepika Jalota Common Stock D 33,065 $1.06 89,959 D S
05 Jun, 2025 Richard A. Heyman Stock Option (right to buy) A 33,500 $0.00 33,500 D A
05 Jun, 2025 Charles M Baum Stock Option (right to buy) A 33,500 $0.00 33,500 D A
05 Jun, 2025 Laurie Stelzer Stock Option (right to buy) A 33,500 $0.00 33,500 D A
05 Jun, 2025 Arnold J Levine Stock Option (right to buy) A 33,500 $0.00 33,500 D A